INTECH Investment Management’s Arbutus Biopharma ABUS Stock Holding History

INTECH Investment Management’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$167K	Buy	34,835 +1,261	+4%	+$5.54K	﹤0.01%	1832
2026 Q1	$151K	Sell	33,574 -36,989	-52%	-$162K	﹤0.01%	1818
2025 Q4	$339K	Buy	70,563 +23,074	+49%	+$104K	﹤0.01%	1696
2025 Q3	$216K	Sell	47,489 -28,360	-37%	-$104K	﹤0.01%	2022
2025 Q2	$234K	Hold	75,849	–	–	﹤0.01%	2006
2025 Q1	$265K	Buy	75,849 +18,765	+33%	+$62.6K	﹤0.01%	1957
2024 Q4	$187K	Buy	57,084 +20,232	+55%	+$74.4K	﹤0.01%	2056
2024 Q3	$142K	Buy	+36,852	New	+$141K	﹤0.01%	1821

Other funds holding ABUS

TSC

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

INTECH Investment Management's ABUS Position: Q2 2026 in Review

INTECH Investment Management increased its Arbutus Biopharma (ABUS) stake by 3.8% in Q2 2026, buying an estimated $5.54K and bringing the position to 34,835 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #1832.

INTECH Investment Management first reported a position in ABUS in Q3 2024 and has held it in 8 quarters since. The position peaked at $339K in Q4 2025. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

INTECH Investment Management held 34,835 shares of Arbutus Biopharma worth $167K as of Q2 2026.
INTECH Investment Management bought 1,261 Arbutus Biopharma shares in Q2 2026, an estimated $5.54K.
Arbutus Biopharma made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1832 holding.
INTECH Investment Management first reported a position in Arbutus Biopharma in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Arbutus Biopharma position peaked at $339K in Q4 2025.
176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.